CRIS Current Research Information System

PANTALEO, MARIA ABBONDANZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.435
AS - Asia 14.639
EU - Europa 10.169
AF - Africa 976
SA - Sud America 831
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 5
Totale 43.081
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.184
SG - Singapore 3.925
VN - Vietnam 3.895
CN - Cina 3.687
IT - Italia 2.171
GB - Regno Unito 2.048
DE - Germania 1.156
SE - Svezia 1.100
HK - Hong Kong 939
FR - Francia 678
IN - India 642
RU - Federazione Russa 576
BR - Brasile 548
IE - Irlanda 411
CH - Svizzera 384
FI - Finlandia 323
KR - Corea 317
NL - Olanda 308
BD - Bangladesh 306
UA - Ucraina 301
CI - Costa d'Avorio 265
ZA - Sudafrica 249
JP - Giappone 237
TG - Togo 215
EE - Estonia 164
CA - Canada 155
AR - Argentina 106
AT - Austria 104
SC - Seychelles 95
JO - Giordania 88
ID - Indonesia 87
PH - Filippine 87
PL - Polonia 87
BG - Bulgaria 86
BE - Belgio 72
NG - Nigeria 68
TH - Thailandia 63
IQ - Iraq 57
TW - Taiwan 54
MX - Messico 51
TR - Turchia 42
ES - Italia 40
EC - Ecuador 38
PK - Pakistan 38
GR - Grecia 36
CL - Cile 34
CO - Colombia 31
IR - Iran 30
AU - Australia 23
MY - Malesia 23
SA - Arabia Saudita 21
PY - Paraguay 20
UZ - Uzbekistan 20
LT - Lituania 19
PE - Perù 17
RO - Romania 17
HR - Croazia 16
VE - Venezuela 16
UY - Uruguay 15
MA - Marocco 14
LB - Libano 13
EG - Egitto 11
SK - Slovacchia (Repubblica Slovacca) 11
CZ - Repubblica Ceca 9
ET - Etiopia 9
JM - Giamaica 9
KE - Kenya 9
TN - Tunisia 9
AO - Angola 8
DZ - Algeria 8
IL - Israele 8
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
NO - Norvegia 7
NP - Nepal 7
AL - Albania 6
CR - Costa Rica 6
DK - Danimarca 5
HU - Ungheria 5
LA - Repubblica Popolare Democratica del Laos 5
MU - Mauritius 5
NI - Nicaragua 5
PS - Palestinian Territory 5
SI - Slovenia 5
MM - Myanmar 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GH - Ghana 3
GT - Guatemala 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
SV - El Salvador 3
Totale 43.031
Salva come PNG Salva come JPEG
Città #
Singapore 2.730
Ashburn 1.867
Southend 1.784
Fairfield 1.462
Chandler 1.165
San Jose 892
Hong Kong 872
Ho Chi Minh City 826
Woodbridge 736
Hanoi 680
Wilmington 675
Houston 671
Hefei 661
Seattle 623
Santa Clara 608
Bologna 552
Cambridge 497
Princeton 488
Beijing 462
Dong Ket 458
Ann Arbor 444
Dublin 411
Boardman 392
Bern 345
Seoul 275
Lauterbourg 268
Abidjan 265
New York 263
Helsinki 257
Los Angeles 249
Dallas 231
Council Bluffs 221
Lomé 215
Nanjing 208
Westminster 195
Tokyo 189
Redmond 184
Padova 159
Berlin 157
Jacksonville 154
Haiphong 140
Milan 128
Da Nang 120
Buffalo 119
Jinan 116
São Paulo 110
Frankfurt am Main 105
Turin 96
Redondo Beach 95
Rome 91
San Diego 89
Amman 86
Shenyang 86
Sofia 86
Guangzhou 77
Munich 75
Saint Petersburg 75
Changsha 73
Warsaw 70
Brussels 67
Nanchang 67
Bengaluru 63
Chicago 62
Vienna 62
Abeokuta 61
Shanghai 61
Hebei 60
Toronto 60
Medford 59
Jakarta 58
Tianjin 57
Falls Church 56
Johannesburg 56
Phoenix 56
Des Moines 54
Zhengzhou 51
Hangzhou 50
Jiaxing 50
London 49
Bremen 48
Florence 48
Montreal 48
Biên Hòa 47
Orem 47
Lappeenranta 45
Dearborn 42
Hyderabad 42
Amsterdam 40
Hải Dương 40
Mülheim 39
Yubileyny 39
San Francisco 38
Olalla 36
Atlanta 35
Nuremberg 35
Shenzhen 35
The Dalles 34
Kuban 33
Denver 32
Paris 31
Totale 27.621
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 461
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 398
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 304
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 282
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 275
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 263
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 260
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 260
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options 257
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 256
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 252
Cardiac metastasis of melanoma. 247
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 247
Hippo pathway targeting in TP53-mutant Uterine Leiomyosarcoma 247
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 246
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 243
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 242
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 238
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 237
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 234
Genomic Characterization of Rare Primary Cardiac Sarcoma Entities 233
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 228
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 226
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 222
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 222
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 222
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 221
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 221
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors 215
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 214
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 214
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 213
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 213
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 213
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs 211
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility 211
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 210
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 209
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 209
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies 208
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 208
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 208
Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading 208
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 207
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 207
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 206
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. 205
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 205
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 205
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 203
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 202
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 201
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 200
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 197
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 197
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 196
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 196
Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas 195
In Reply 195
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 195
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 195
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 194
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 193
Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches 193
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 193
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 193
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 192
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 190
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 190
Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an omic approach to identify novel druggable targets 190
Efficacy and biological activity of imatinib in metastatic Dermatofibrosarcoma Protuberans (DFSP) 190
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 189
Activity of sunitinib in extraskeletal myxoid chondrosarcoma. 189
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib. 187
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 187
ACTIVATED NF-KB IN COLORECTAL CANCER: PREDICTIVE OR PROGNOSTIC FACTOR? 186
Multimodality Imaging in the Diagnostic Work-Up of Patients With Cardiac Masses 185
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 185
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 184
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 183
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 183
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 182
Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review. 181
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 180
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 179
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy 176
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 176
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 176
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update 175
Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis 175
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 175
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 174
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 174
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 173
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 173
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 172
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 171
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 171
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 171
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 171
Totale 21.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021955 0 0 0 0 0 0 0 0 0 0 0 955
2021/20224.637 487 183 229 367 388 211 108 395 256 277 968 768
2022/20235.399 587 782 291 634 325 352 153 323 859 172 398 523
2023/20241.665 169 262 89 185 132 301 85 122 60 84 86 90
2024/20256.067 294 802 534 440 933 287 478 257 114 427 311 1.190
2025/202615.609 1.485 1.279 1.297 1.092 1.544 879 1.817 483 3.180 1.260 713 580
Totale 43.953